Zynex, Inc. ZYXI
0.13 USD 0.00 (+0.00%)
At closeApr 2, 2026, 4:00 PM EDT
0.13 +0.01 +4.00%
After hours · Apr 2, 4:00 PM ET
0.125 Day range 0.125
52-week range unavailable
- YTD
- -98.44%
- 1 year
- -98.48%
Analyst view
Price target (mean) 17.50 +13900.0% upside
Now 0.125
- Target (low)
- 11.00
- Target (mean)
- 17.50
- Target (high)
- 24.50
Ratings (0m) 3 3 buy · 0 hold · 0 sell
- Strong buy2
- Buy1
- Hold0
- Sell0
- Strong sell0
Recommendation trend
- This month 3
- 1 month ago 3
- 2 months ago 3
Earnings and revenue estimates
Consensus for the coming quarters and fiscal years
| Period | EPS estimate | Low – high | Year ago | EPS growth | Revenue estimate | Revenue growth | Analysts |
|---|---|---|---|---|---|---|---|
| Current quarter | 0.09 | 0.09 – 0.09 | 0.1568 | -42.6% | 53.65M | +13.5% | 3 |
| Next quarter | 0.06 | 0.05 – 0.07 | 0.00 | 0.0% | 53.46M | +14.9% | 3 |
| Current year | 0.20 | 0.20 – 0.20 | 0.00 | 0.0% | 200.04M | +8.5% | 3 |
| Next year | 0.47667 | 0.45 – 0.50 | 0.20 | +138.3% | 239.60M | +19.8% | 3 |
Upgrades and downgrades
The latest rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Dec 6, 2024 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Oct 25, 2024 | HC Wainwright & Co. | Maintained | Buy | Buy |
| Oct 8, 2024 | RBC Capital | Maintained | Outperform | Outperform |
| Sep 4, 2024 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Jul 26, 2024 | RBC Capital | Maintained | Outperform | Outperform |
| Jul 26, 2024 | HC Wainwright & Co. | Maintained | Buy | Buy |
| Jun 14, 2024 | RBC Capital | Reiterated | Outperform | Outperform |
| May 1, 2024 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Mar 1, 2024 | RBC Capital | Maintained | Outperform | Outperform |
| Mar 1, 2024 | HC Wainwright & Co. | Maintained | Buy | Buy |
| Oct 16, 2023 | RBC Capital | Initiated | — | Outperform |
| Apr 28, 2023 | HC Wainwright & Co. | Reiterated | — | Buy |
| Apr 12, 2023 | HC Wainwright & Co. | Reiterated | — | Buy |
| Mar 28, 2023 | Ladenburg Thalmann | Maintained | — | Buy |
| Mar 14, 2023 | HC Wainwright & Co. | Reiterated | — | Buy |
| Jan 6, 2023 | Piper Sandler | Upgrade | Neutral | Overweight |
| Oct 28, 2022 | Piper Sandler | Maintained | — | Neutral |
| Oct 28, 2022 | HC Wainwright & Co. | Maintained | — | Buy |
| Feb 25, 2022 | HC Wainwright & Co. | Maintained | — | Buy |
| Jul 30, 2021 | HC Wainwright & Co. | Maintained | — | Buy |
| Jul 16, 2021 | B. Riley Securities | Upgrade | Neutral | Buy |
| Mar 9, 2021 | Northland Capital Markets | Upgrade | Market Perform | Outperform |
| Jan 29, 2021 | Piper Sandler | Downgrade | Overweight | Neutral |
| Jan 28, 2021 | Northland Capital Markets | Downgrade | Outperform | Market Perform |
| Sep 14, 2020 | HC Wainwright & Co. | Upgrade | Neutral | Buy |
| Sep 9, 2020 | Northland Capital Markets | Upgrade | Market Perform | Outperform |
| Jul 29, 2020 | B. Riley Securities | Upgrade | Neutral | Buy |
| Jul 29, 2020 | HC Wainwright & Co. | Maintained | — | Neutral |
| Jul 20, 2020 | Piper Sandler | Initiated | — | Overweight |
| Jul 13, 2020 | B. Riley Securities | Downgrade | Buy | Neutral |